SCHEMBL2742278

SCHEMBL2742278

CC(OCCc1ccccc1)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
FFAR1 O14842 1/20 0.40
GAA P10253 1/20 0.40
PPARG P37231 4/20 0.39
PPARA Q07869 3/20 0.39
SIGMAR1 Q99720 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10231956 0.89 RAB9A (0.42) NPC1RAB9AFFAR1PPARGPPARA
SCHEMBL4449191 0.86 CA1 (0.44) NPC1RAB9ASIGMAR1CA1CA2
SCHEMBL13131032 0.86 NPC1 (0.37) NPC1RAB9AFFAR1PPARGPPARA
SCHEMBL13131157 0.86 NPC1 (0.37) NPC1RAB9AFFAR1PPARGPPARA
SCHEMBL18746060 0.86 FFAR1 (0.40) NPC1RAB9AFFAR1PPARGPPARA
SCHEMBL685739 0.85 PPARG (0.38) NPC1RAB9AFFAR1GAAPPARG
SCHEMBL111636 0.85 SLC7A5 (0.47) NPC1RAB9AFFAR1GAATDP1
SCHEMBL14289791 0.85 SLC7A5 (0.47) NPC1RAB9AFFAR1GAATDP1
SCHEMBL26015238 0.85 NPC1 (0.40) NPC1RAB9AFFAR1PPARGPPARA
SCHEMBL685853 0.83 PPARG (0.41) NPC1RAB9AFFAR1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550562-B1 PATTERN FORMING METHOD AND RESIST COMPOSITION FUJIFILM CORP (JP) 2021-04-21 EP disclosed
EP-2539769-B1 PATTERN FORMING METHOD AND RESIST COMPOSITION FUJIFILM CORP (JP) 2021-04-07 EP disclosed
US-10802399-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2020-10-13 US disclosed
US-10761424-B2 2020-09-01 US disclosed
US-10649329-B2 Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, and electronic device FUJIFILM CORPORATION (JP) 2020-05-12 US disclosed
US-10444627-B2 Pattern formation method, active light-sensitive or radiation-sensitive resin composition, resist film, production method for electronic device using same, and electronic device FUJIFILM CORPORATION (JP) 2019-10-15 US disclosed
US-9829796-B2 Pattern formation method, active light-sensitive or radiation-sensitive resin composition, resist film, production method for electronic device using same, and electronic device FUJIFILM CORPORATION (JP) 2017-11-28 US disclosed
US-9829796-B2 Pattern formation method, active light-sensitive or radiation-sensitive resin composition, resist film, production method for electronic device using same, and electronic device FUJIFILM CORPORATION (JP) 2017-11-28 US disclosed
US-9766547-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device FUJIFILM CORPORATION (JP) 2017-09-19 US disclosed
US-9766547-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device FUJIFILM CORPORATION (JP) 2017-09-19 US disclosed
US-7632623-B2 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2009-12-15 US disclosed
US-7632623-B2 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2009-12-15 US disclosed
US-7442490-B2 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2008-10-28 US disclosed
US-7442490-B2 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2008-10-28 US disclosed
US-20080206669-A1 POSITIVE WORKING RESIST COMPOSITION AND PATTERN FORMING METHOD FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
US-20080206669-A1 POSITIVE WORKING RESIST COMPOSITION AND PATTERN FORMING METHOD FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
US-20070218405-A1 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2007-09-20 US disclosed
US-20070218405-A1 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION (JP) 2007-09-20 US disclosed
US-20070105045-A1 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION 2007-05-10 US disclosed
US-20070105045-A1 Positive resist composition and pattern formation method using the positive resist composition FUJIFILM CORPORATION 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10761424-B2 GLRA1, RER1, ACTR5 NPC1 3679/4885RAB9A 1138/4885FFAR1 162/4885
US-10802399-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device RER1, ACTR5, GLRA1 NPC1 3964/4885RAB9A 626/4885FFAR1 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.